A drug designed to combat Tuberous Sclerosis is being trialled at Cardiff University and could also be used to treat autism. Everolimus has already proven effective when used to treat kidney growths and grain tumours - reducing their size in many cases.
Tuberous Sclerosis is a genetic disorder characterised by the development of tumours in many organs, including the skin and kidneys. It can also affect the brain, leading to epilepsy and often ADHD and autism.
For more health stories click here.
More top news
Catch up with the latest episode of Coast & Country. This week the team are on Anglesey!
Property website Rightmove said there are signs of a "strong spring market".
Drivers caught speeding excessively can now expect fines starting from 150% of their weekly income.